OK results for Q4 18. PBT of 2 .11 Cr vs loss of 2.12 Cr in Q4 FY 17, but lower than PBT of 3.46 in Q3 18. Big PAT loss of 13 Cr due to deferred tax entry of 15.28 Cr this quarter.
“Considering that India has a huge and overall income levels are going up we know that healthcare overall space is going to become very big. Today in India about $1.5 billion business is done for diagnostic imaging versus total global, it is more like a $50 billion so what it means is that we are doing about 2% of global business whereas our population is more like a 15 percent. So if everything is equal you have an opportunity to go from 2% to 16%… because there is participation by a lot of corporate houses, lot of nursing homes are coming up, government is also investing and as we know Ayushman Bharat is going to further fuel the growth big time.”
“BPL was the first company to make a medical device in India, the first manufacturer of the medical equipments like ECG and couple of those monitors at that point and time. We kept our focus only to some of those products but 5 years back, those investments from Goldman Sachs in BPL… We have added lot of verticals now. We have added radiology, where we are now manufacturing X-ray machines, we have ultrasounds and we have also added critical care and in that space we felt that anaesthesia has a big business and is a very needed product in all the hospitals…”